Assertio Therapeutics Inc (ASRT)
NASDAQ:ASRT
Holding ASRT?
Track your performance easily

Assertio Therapeutics (ASRT) Financial Statements

1,051 Followers

Assertio Therapeutics Financial Overview

Assertio Therapeutics's market cap is currently ―. The company's EPS TTM is $-4.113; its P/E ratio is -0.32; Assertio Therapeutics is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 31.13M$ 32.45M$ 32.98M$ 35.63M$ 40.99M
Gross Profit$ 22.24M$ 21.27M$ 23.26M$ 28.57M$ 36.22M
EBIT$ -2.77M$ -3.62M$ -31.25M$ -228.13M$ 13.08M
EBITDA$ 4.05M$ 2.18M$ -26.35M$ -217.67M$ 19.66M
Net Income Common Stockholders$ -3.67M$ -4.51M$ -57.38M$ -279.54M$ 8.47M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 88.38M$ 80.74M$ 73.44M$ 76.89M$ 70.17M
Total Assets$ 279.44M$ 281.96M$ 286.42M$ 380.03M$ 405.18M
Total Debt$ 38.73M$ 38.62M$ 38.51M$ 38.87M$ 38.25M
Net Debt$ -49.65M$ -42.12M$ -34.93M$ -38.02M$ -31.92M
Total Liabilities$ 147.29M$ 147.47M$ 148.42M$ 187.16M$ 150.91M
Stockholders Equity$ 132.15M$ 134.49M$ 138.00M$ 192.87M$ 254.27M
Cash Flow-
Free Cash Flow$ 7.39M$ 7.51M$ 5.89M$ 2.58M$ 17.90M
Operating Cash Flow$ 7.39M$ 7.51M$ 5.71M$ 2.58M$ 18.60M
Investing Cash Flow$ -43.32M-$ -239.00K$ 4.14M$ -703.00K
Financing Cash Flow$ -75.00K$ -206.00K$ -8.91M$ -10.00K$ -16.33M
Currency in USD

Assertio Therapeutics Earnings and Revenue History

Assertio Therapeutics Debt to Assets

Assertio Therapeutics Cash Flow

Assertio Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis